- $1.07bn
- $1.36bn
- $441.33m
Artivion Inc reports results for the quarter ended December 31 - Earnings Summary
Artivion Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: Artivion Granted FDA Humanitarian Device Exemption For The AMDS Hybrid Prosthesis
Artivion Inc reports results for the quarter - Earnings Summary
Brief: Artivion Q3 Revenue USD 95.779 Million Vs. IBES Estimate USD 94.8 Million
Brief: Artivion Q2 Revenue USD 98.019 Million Vs. IBES Estimate USD 97.7 Million
Artivion Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: Artivion Says Endospan Receives Additional $25 Mln From Co For Nexus FDA Approval Path
Brief: Artivion Amends Agreements With Endospan
U.S. STOCKS ON THE MOVE-Henry Schein, Dave, Delek
U.S. STOCKS ON THE MOVE-Vanda Pharmaceuticals, FMC, Duke Energy
Artivion eyes biggest gain in 3 years after Q1 beat
Brief: Artivion Q1 Revenue USD 97.431 Million Vs. IBES Estimate USD 92 Million
Artivion Inc expected to post a loss of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE- Applied Materials, Trade Desk, crypto stocks
Artivion Inc reports results for the quarter ended in December - Earnings Summary
Brief: Artivion Q4 Revenue USD 93.67 Million Vs. IBES Estimate USD 89.3 Million
Artivion Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Artivion Obtains $350 Mln In Senior Secured Credit Facilities